SCHEMBL2590640

SCHEMBL2590640

O=P(c1ccccc1)(c1ccccc1)c1cnc2ccccn12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.69
GGPS1 O95749 1/20 0.44
FDPS P14324 1/20 0.44
EPHB3 P54753 1/20 0.43
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
ADORA3 P0DMS8 1/20 0.42
FLT3 P36888 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
GPR84 Q9NQS5 1/20 0.39
MIF P14174 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 2/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2587965 0.81 NPSR1 (1.00) NPSR1GGPS1FDPSEPHB3NPC1
SCHEMBL496758 0.70 NPC1 (0.60) NPSR1GGPS1FDPSEPHB3NPC1
Hydrochloric Acid SCHEMBL21834227 0.69 NPC1 (0.59) NPSR1GGPS1FDPSEPHB3NPC1
SCHEMBL3836508 0.68 NPC1 (0.57) NPSR1GGPS1FDPSEPHB3NPC1
Phosphoric Acid SCHEMBL29440774 0.68 NPC1 (0.54) NPSR1GGPS1FDPSEPHB3NPC1
SCHEMBL2591865 0.68 NPSR1 (1.00) NPSR1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14756611 0.67 NPC1 (0.53) NPSR1GGPS1FDPSEPHB3NPC1
SCHEMBL16797995 0.67 DDR2 (0.69) EPHB3NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL11266749 0.67 NPC1 (0.78) NPSR1EPHB3NPC1RAB9ASMN1; SMN2
SCHEMBL30552182 0.67 EPHB3 (0.63) GGPS1FDPSEPHB3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed